Bernstein SocGen raises CrowdStrike stock price target to $371

Bernstein SocGen raised its price target for CrowdStrike (CRWD) to $371, maintaining an Outperform rating, after the company's Q1 FY26 earnings met guidance but didn't exceed expectations. The revised model anticipates a growth recovery and projects 116% net revenue retention by the start of FY27 despite a weaker-than-expected Q1. Analyst sentiment is mixed, with Stephens and Scotiabank raising their price targets to $540 and $480 respectively, while BofA Securities downgraded the stock to neutral with a $470 target, citing valuation concerns despite anticipated growth acceleration.

Analysis

CrowdStrike Holdings (CRWD) recently announced fiscal first-quarter 2026 results featuring strong annual recurring revenue (ARR) performance, though overall revenue met the midpoint of guidance rather than exceeding expectations and was described by some as slightly below or weaker-than-expected. In response, Bernstein SocGen Group raised its price target to $371 from $347, maintaining an Outperform rating, and projects approximately 116% net revenue retention by fiscal year 2027, anticipating a growth recovery. CrowdStrike management expressed confidence in robust demand and expects growth to accelerate in the second half of the year, citing positive channel checks and its reported 26% revenue growth. The stock, trading near its 52-week high at $488.76 after a nearly 43% year-to-date gain, is considered by InvestingPro analysis to be above its Fair Value. This valuation concern contributed to BofA Securities downgrading the stock to Neutral with a $470 target, despite acknowledging the anticipated growth. Conversely, other analysts remain optimistic: Stephens set a $540 target, UBS reiterated a Buy with a $545 target highlighting strong net new ARR and free cash flow, and Raymond James raised its target to $485. Scotiabank also increased its target to $480 but holds a Sector Perform rating, citing market maturity concerns. This divergence in analyst ratings, with price targets ranging from $321 to $550, underscores the current debate between CrowdStrike's compelling growth trajectory and its elevated valuation.

Key Decisions for Investors

• Given CrowdStrike's significant year-to-date appreciation to near its 52-week high and InvestingPro's assessment of it trading above Fair Value, alongside BofA's valuation concerns, investors should exercise caution regarding new entry points and be prepared for potential volatility.
• Investors should closely monitor upcoming quarterly reports for evidence of the anticipated second-half growth acceleration and achievement of the projected 116% net revenue retention, as these are crucial factors for justifying the current stock valuation.
• The wide range of analyst price targets ($321 to $550) and mixed ratings necessitate a careful assessment, balancing the company's strong market position and growth outlook against prevailing valuation risks and concerns about market maturity.